Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation: 05/01/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 9 January 2026 - 10:35

Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation: 05/01/2024, Revision: 4, Status: Authorised

Fifteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 November 2025, 09:00 (CET) to 28 November 2025, 13:00 (CET)

Submitted by Anonymous (not verified) on 8 January 2026 - 16:04

Fifteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 November 2025, 09:00 (CET) to 28 November 2025, 13:00 (CET)

Sixth European Medicines Agency (EMA) and the Association of the European Self-Care Industry (AESGP) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 January 2026, 14:00 (CET) to 23 January 2026, 16:00 (CET)

Submitted by Anonymous (not verified) on 8 January 2026 - 15:06

Sixth European Medicines Agency (EMA) and the Association of the European Self-Care Industry (AESGP) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 January 2026, 14:00 (CET) to 23 January 2026, 16:00 (CET)

Seventh European Medicines Agency - EuropaBio bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 20 January 2026, 11:00 (CET) to 20 January 2026, 13:00 (CET)

Submitted by Anonymous (not verified) on 8 January 2026 - 15:02

Seventh European Medicines Agency - EuropaBio bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 20 January 2026, 11:00 (CET) to 20 January 2026, 13:00 (CET)

Human medicines European public assessment report (EPAR): Reagila, cariprazine, Date of authorisation: 13/07/2017, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 8 January 2026 - 14:50

Human medicines European public assessment report (EPAR): Reagila, cariprazine, Date of authorisation: 13/07/2017, Revision: 12, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness